semaglutide gut microbiome alleviates microbiota dysbiosis induced by a high-fat diet The gut microbiota in obesity

Rybelsus 7mg Tablet 10s used for Type 2 diabetes mellitus

The morphology, impurity levels, aggregate formation, and aerodynamic particle size distribution of semaglutide-loaded DPI were assessed

Inphase 3 clinical trials (SURPASS 1-5), the dose-dependent efficacy and safety of tirzepatide were assessed by once-weekly subcutaneous injection (5mg, 10mg, and 15 mg), as monotherapy or combination therapy, in individuals with T2DM

Limited evidence suggests that combined SGLT2is/GLP1-RAs therapy can potentially improve most but not all outcomes

In conclusion, many patients receiving GLP-1RA suffer from Ozempic face and facial aging

A professional's guide to managing the side effects of weight loss and skin health.